Tag: Aiha

According to a 37-year Danish study, the median survival for primary autoimmune hemolytic anemia (AIHA) is 9.8 years, while for secondary AIHA it is 3.3 years. This highlights that life expectancy with hemolytic anemia is not a single, fixed number but depends heavily on the type of condition and other factors.

While the prognosis for autoimmune hemolytic anemia (AIHA) has improved over recent decades, a nationwide study found that patients still experience a considerably higher overall mortality rate than the general population. Understanding **what is the mortality rate for autoimmune hemolytic anemia** requires looking beyond a single number and considering several key variables, including whether the disease is primary or secondary.

The human body produces millions of red blood cells every second, each living for about 120 days before being recycled. Hemolytic anemia is a type of blood disorder where red blood cells are destroyed faster than the bone marrow can produce new ones, leading to an insufficient supply to carry oxygen.